Abstract
Facial paralysis afflicts a significant number of individuals annually. Although Bell’s palsy is the most common cause of facial paralysis, that diagnosis can be hastily made, and life-threatening conditions and appropriate treatments for other causes can be missed. Facial paralysis increases the risk of ocular damage and poor vision; hinders the ability to eat, drink, and speak effectively; and often results in a negative self-image. Aberrant nerve regeneration with facial spasm, synkinetic movement, and excessive tearing are long-term problems that also need to be managed.
Proper diagnosis, evaluation of the deficits with physical examination and imaging when needed, and instituting proper multidisciplinary management early in the disease process will optimize patient care and reduce the risk of permanent injury and deficits especially involving the eye. Although every practitioner will not be able to address all the issues involved with facial paralysis patients, understanding what treatments and interventions are available will facilitate appropriate and early referral to centers that can provide comprehensive care for these patients.
References
Holland NJ, Bernstein JM. Bell’s palsy. BMJ Clin Evid. 2014;2014:1204.
McCormick DP. Herpes-simplex virus as a cause of Bell's palsy. Lancet. 1972;1(7757):937–9.
Murakami S, et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;124(1 Pt 1):27–30.
Gary S, Remia P. Evidence-based guidelines update: Steroids and antivirals for Bell palsy. Report of the Subcommittee of the American Academy of Neurology. Neurology. 2012;79(22):2209-2213. https://doi.org/10.1212/WNL.0b13e31827978c.
de Almeida JR, et al. Combined corticosteroid and antiviral treatment for bell palsy: a systematic review and meta-analysis. JAMA. 2009;302(9):985–93.
Sullivan FM, et al. A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell’s palsy: the BELLS study. Health Technol Assess. 2009;13(47):iii–iv, ix–xi, 1–130.
Engstrom M, et al. Prednisolone and valaciclovir in Bell’s palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 2008;7(11):993–1000.
Peitersen E. Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl. 2002;(549):4–30. PMID: 12482166.
Ikeda M, et al. Clinical factors that influence the prognosis of facial nerve paralysis and the magnitudes of influence. Laryngoscope. 2005;115(5):855–60.
Gilden DH. Clinical practice. Bell’s palsy. N Engl J Med. 2004;351(13):1323–31.
Phillips KM, et al. Onset of Bell’s palsy in late pregnancy and early puerperium is associated with worse long-term outcomes. Laryngoscope. 2017;127(12):2854–9.
Navarrete ML, et al. Recurrent Bell’s facial palsy: our experience. Acta Otorrinolaringol Esp. 2001;52(8):682–6.
Fujiwara T, et al. Prognostic factors of Bell's palsy: prospective patient collected observational study. Eur Arch Otorhinolaryngol. 2014;271(7):1891–5.
Baugh RF, et al. Clinical practice guideline: Bell’s palsy executive summary. Otolaryngol Head Neck Surg. 2013;149(5):656–63.
Revilla A. Differential diagnosis of tumor of the cerebellopontine recess. Bull Johns Hopkins Hosp. 1948;83:187–212.
Cushing H. Tumors of the nervus acousticus and the syndrome of the cerebellopontine angle. Philadelphia: WB Saunders Company; 1917.
Nguyen J-P, Bendib B, Lacombe H, Keravel Y, Brugières P, Gray F. Intracranial neuromas [French]. In: Neurologie. Paris: Elsevier; 2006.
Kunert P, Smolarek B, Marchel A. Facial nerve damage following surgery for cerebellopontine angle tumours. Prevention and comprehensive treatment. Neurol Neurochir Pol. 2011;45(5):480–8.
Hohman MH, Hadlock TA. Etiology, diagnosis, and management of facial palsy: 2000 patients at a facial nerve center. Laryngoscope. 2014;124(7):E283–93.
Rinaldi V, et al. Facial nerve outcome after vestibular schwannoma surgery: our experience. J Neurol Surg B Skull Base. 2012;73(1):21–7.
Albathi M, et al. Early nerve grafting for facial paralysis after cerebellopontine angle tumor resection with preserved facial nerve continuity. JAMA Facial Plast Surg. 2016;18(1):54–60.
Jacob JT, Driscoll CL, Link MJ. Facial nerve schwannomas of the cerebellopontine angle: the mayo clinic experience. J Neurol Surg B Skull Base. 2012;73(4):230–5.
Jackson CG, et al. Facial paralysis of neoplastic origin: diagnosis and management. Laryngoscope. 1980;90(10 Pt 1):1581–95.
Leonetti JP, et al. Neoplastic causes of nonacute facial paralysis: a review of 221 cases. Ear Nose Throat J. 2016;95(9):390–404.
Bron LP, et al. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases. Laryngoscope. 2003;113(6):1070–5.
Saia V, Pantoni L. Progressive stroke in pontine infarction. Acta Neurol Scand. 2009;120(4):213–5.
Bassetti C, et al. Isolated infarcts of the pons. Neurology. 1996;46(1):165–75.
Oppenheim C, et al. False-negative diffusion-weighted MR findings in acute ischemic stroke. AJNR Am J Neuroradiol. 2000;21(8):1434–40.
Murakami S, et al. Treatment of Ramsay hunt syndrome with acyclovir-prednisone: significance of early diagnosis and treatment. Ann Neurol. 1997;41(3):353–7.
Aleksic SN, Budzilovich GN, Lieberman AN. Herpes zoster oticus and facial paralysis (Ramsay Hunt syndrome). Clinico-pathologic study and review of literature. J Neurol Sci. 1973;20(2):149–59.
Jonsson L, et al. Gd-DPTA enhanced MRI in Bell’s palsy and herpes zoster oticus: an overview and implications for future studies. Acta Otolaryngol. 1995;115(5):577–84.
Uri N, et al. Acyclovir in the treatment of Ramsay Hunt syndrome. Otolaryngol Head Neck Surg. 2003;129(4):379–81.
Kuehn BM. CDC estimates 300,000 US cases of Lyme disease annually. JAMA. 2013;310(11):1110.
Cooper L, et al. Lyme disease and Bell’s palsy: an epidemiological study of diagnosis and risk in England. Br J Gen Pract. 2017;67(658):e329–35.
Jowett N, et al. Steroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomes. Laryngoscope. 2017;127(6):1451–8.
Joseph EM, Sperling NM. Facial nerve paralysis in acute otitis media: cause and management revisited. Otolaryngol Head Neck Surg. 1998;118(5):694–6.
Kangsanarak J, et al. Extracranial and intracranial complications of suppurative otitis media. Report of 102 cases. J Laryngol Otol. 1993;107(11):999–1004.
Ellefsen B, Bonding P. Facial palsy in acute otitis media. Clin Otolaryngol Allied Sci. 1996;21(5):393–5.
Yetiser S, Tosun F, Kazkayasi M. Facial nerve paralysis due to chronic otitis media. Otol Neurotol. 2002;23(4):580–8.
Redaelli de Zinis LO, Gamba P, Balzanelli C. Acute otitis media and facial nerve paralysis in adults. Otol Neurotol. 2003;24(1):113–7.
Montava M, et al. Temporal bone fracture under lateral impact: biomechanical and macroscopic evaluation. Med Biol Eng Comput. 2016;54(2–3):351–60.
Lydiatt DD. Medical malpractice and facial nerve paralysis. Arch Otolaryngol Head Neck Surg. 2003;129(1):50–3.
Falco NA, Eriksson E. Facial nerve palsy in the newborn: incidence and outcome. Plast Reconstr Surg. 1990;85(1):1–4.
Bergman I, et al. Management of facial palsy caused by birth trauma. Laryngoscope. 1986;96(4):381–4.
Zuker RSaRM. Congenital facial weakness. In: Azizzadeh WHSaB, editor. Facial nerve. Stuttgart: Thieme Medical Published; 2014.
Kaur R, Morris M, Pichichero ME. Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era. Pediatrics. 2017;140(3):18.
Gaio E, et al. Facial nerve paralysis secondary to acute otitis media in infants and children. J Paediatr Child Health. 2004;40(8):483–6.
Tveitnes D, Oymar K, Natas O. Acute facial nerve palsy in children: how often is it Lyme borreliosis? Scand J Infect Dis. 2007;39(5):425–31.
Ujma B, Krzystanek W, Roznatowska A. Melkersson-Rosenthal syndrom (author’s transl). Przegl Lek. 1980;37(10):719–20.
Gaudin RA, et al. Bilateral facial paralysis: a 13-year experience. Plast Reconstr Surg. 2016;138(4):879–87.
Evans DG. Neurofibromatosis type 2. Handb Clin Neurol. 2015;132:87–96.
Sejvar JJ, et al. Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–33.
Bhargava A, et al. A study of Guillain-Barre syndrome with reference to cranial neuropathy and its prognostic implication. J Neurosci Rural Pract. 2014;5(Suppl 1):S43–7.
Winer JB, Hughes RA, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry. 1988;51(5):605–12.
Hoyle JC, Jablonski C, Newton HB. Neurosarcoidosis: clinical review of a disorder with challenging inpatient presentations and diagnostic considerations. Neurohospitalist. 2014;4(2):94–101.
Homer N, Fay A. Management of long-standing flaccid facial palsy: periocular considerations. Otolaryngol Clin N Am. 2018;51(6):1107–18. https://doi.org/10.1016/j.otc.2018.07.007. Epub 2018 Aug 28
Ziahosseini K, Nduka C, Malhotra R. Ophthalmic grading of facial paralysis: need for a closer look. Br J Ophthalmol. 2015;99(9):1171–5. https://doi.org/10.1136/bjophthalmol-2014-305716. Epub 2015 Jan 6
Bhama PK, Hadlock TA. Contemporary facial reanimation. Facial Plast Surg. 2014;30(2):145–51. https://doi.org/10.1055/s-0034-1371900. Epub 2014 May 8
Custer PL. Ophthalmic management of the facial palsy patient. Semin Plast Surg. 2004;18(1):31–8. https://doi.org/10.1055/s-2004-823121.
Allen RC. Controversies in periocular reconstruction for facial nerve palsy. Curr Opin Ophthalmol. 2018;29(5):423–7. https://doi.org/10.1097/ICU.0000000000000510.
Henstrom DK, Lindsay RW, Cheney ML, Hadlock TA. Surgical treatment of the periocular complex and improvement of quality of life in patients with facial paralysis. Arch Facial Plast Surg. 2011;13(2):125–8. https://doi.org/10.1001/archfacial.2011.9.
Golio D, De Martelaere S, Anderson J, Esmaeli B. Outcomes of periocular reconstruction for facial nerve paralysis in cancer patients. Plast Reconstr Surg. 2007;119(4):1233–7.
Joseph SS, Joseph AW, Douglas RS, Massry GG. Periocular reconstruction in patients with facial paralysis. Otolaryngol Clin N Am. 2016;49(2):475–87. https://doi.org/10.1016/j.otc.2015.10.011.
Maqsood SE, Cascone N, Grixti A, Kannan R, Nduka C, Malhotra R. Functional and aesthetic outcomes of eyelid skin grafting in facial nerve palsy. Br J Ophthalmol. 2018; https://doi.org/10.1136/bjophthalmol-2018-312311. pii: bjophthalmol-2018-312311. [Epub ahead of print].
Tan ST, Staiano JJ, Itinteang T, McIntyre BC, MacKinnon CA, Glasson DW. Gold weight implantation and lateral tarsorrhaphy for upper eyelid paralysis. J Craniomaxillofac Surg. 2013;41(3):e49–53. https://doi.org/10.1016/j.jcms.2012.07.015. Epub 2012 Aug 14
Bran GM, Börjesson PK, Boahene KD, Gosepath J, Lohuis PJ. Effect of endoscopic brow lift on contractures and synkinesis of the facial muscles in patients with a regenerated postparalytic facial nerve syndrome. Plast Reconstr Surg. 2014;133(1):121–9. https://doi.org/10.1097/01.prs.0000436834.19066.7c.
Siah WF, Nagendran S, Tan P, Ali Ahmad SM, Litwin AS, Malhotra R. Late outcomes of gold weights and platinum chains for upper eyelid loading. Br J Ophthalmol. 2018;102(2):164–8. https://doi.org/10.1136/bjophthalmol-2016-310089. Epub 2017 Jul 8.
Malik A, Joshi N. Gold in the balance: how does patient posture affect eyelid closure? Orbit. 2017;36(5):347–9. https://doi.org/10.1080/01676830.2017.1337176. Epub 2017 Jul 5
Wagh VK, Lim WS, Cascone NC, Morley AM. Post-septal upper eyelid loading for treatment of exposure keratopathy secondary to non-cicatricial lagophthalmos. Orbit. 2016;35(5):239–44. https://doi.org/10.1080/01676830.2016.1176213. Epub 2016 Aug 10
Rozen S, Lehrman C. Upper eyelid postseptal weight placement for treatment of paralytic lagophthalmos. Plast Reconstr Surg. 2013;131(6):1253–65. https://doi.org/10.1097/PRS.0b013e31828be961.
Mavrikakis I, Beckingsale P, Lee E, Riaz Y, Brittain P. Changes in corneal topography with upper eyelid gold weight implants. Ophthalmic Plast Reconstr Surg. 2006;22(5):331–4.
Salloum G, Carruth BP, Hill RH 3rd, Czyz CN, Bersani TA. Transitioning from a gold weight to an “enhanced” palpebral spring in the management of paralytic lagophthalmos secondary to facial nerve palsy. Orbit. 2019;38(2):119–23. https://doi.org/10.1080/01676830.2018.1497067. Epub 2018 Jul 26
Sales-Sanz M, Barrancos C, Won-Kim HR, Sales-Sanz A, Colmenero C. Reconstructive sbperiosteal midface lift: a three nonvisible incision approach. Orbit. 2017;36(5):256–63. https://doi.org/10.1080/01676830.2017.1337166. Epub 2017 Jul 5
Pascali M, Botti C, Cervelli V, Botti G. Vertical midface lifting with periorbital anchoring in the management of lower eyelid retraction: a 10-year clinical retrospective study. Plast Reconstr Surg. 2017;140(1):33–45. https://doi.org/10.1097/PRS.0000000000003452.
Compton CJ, Clark JD, Nunery WR, Lee HB. Recession and extirpation of the lower eyelid retractors for paralytic Lagophthalmos. Ophthalmic Plast Reconstr Surg. 2015;31(4):323–4. https://doi.org/10.1097/IOP.0000000000000485.
Iyengar SS, Burnstine MA. Treatment of symptomatic facial nerve paralysis with lower eyelid fascia lata suspension. Plast Reconstr Surg. 2012;129(3):569e–71e. https://doi.org/10.1097/PRS.0b013e3182419d4b.
Elner VM, Mauffray RO, Fante RG, Harris M, Morton AD, Hassan AS. Comprehensive midfacial elevation for ocular complications of facial nerve palsy. Arch Facial Plast Surg. 2003;5(5):427–33.
Alford EL. The SOOF lift as an adjunct in rehabilitation of facial paralysis: help or hype? Facial Plast Surg. 2000;16(4):345–9.
Dedhia R, Hsieh TY, Chin O, Shipchandler TZ, Tollefson TT. Outcomes from lateral eyelid coupling for facial paralysis using the modified Tarsoconjunctival flap. JAMA Facial Plast Surg. 2018;20(5):381–6. https://doi.org/10.1001/jamafacial.2018.0070.
Guelinckx PJ. Blink restoration in long-standing facial paralysis: use of free neurovascular platysma transfer. Plast Reconstr Surg Glob Open. 2018;6(10):e1939. https://doi.org/10.1097/GOX.0000000000001939. eCollection 2018 Oct
Roggenkämper P, Laskawi R, Damenz W, Schröder M, Nüssgens Z. Orbicular synkinesis after facial paralysis: treatment with botulinum toxin. Doc Ophthalmol. 1994;86(4):395–402.
Simpson LL. Identification of the major steps in botulinum toxin action. Ann Rev Pharmacol Toxicol. 2004;44:167–93. https://doi.org/10.1146/annurev.pharmtox.44.101802.121554.
van Veen MM, Dusseldorp JR, Hadlock TA. Long-term outcome of selective neurectomy for refractory periocular synkinesis. Laryngoscope. 2018;128(10):2291–5. PMID: 29668050. https://doi.org/10.1002/lary.27225. Epub 2018 Apr 18
Loyo M, Jones D, Lee LN, Collar RM, Molendijk J, Boahene KD, Ishii LE, Byrne PJ. Treatment of the periocular complex in paralytic lagophthalmos. Ann Otol Rhinol Laryngol. 2015;124(4):273–9. https://doi.org/10.1177/0003489414560584. Epub 2014 Dec 4
Lindsay RW, et al. Correction of the nasal base in the flaccidly paralyzed face: an orphaned problem in facial paralysis. Plast Reconstr Surg. 2010;126(4):185e–6e.
Joseph AW, Kim JC. Management of flaccid facial paralysis of less than two years’ duration. Otolaryngol Clin N Am. 2018;51(6):1093–105.
Salmeron-Gonzalez E, et al. Masseter-to-facial nerve transfer for reanimation of a patient with long-term facial paralysis. J Craniofac Surg. 2019;30(1):e43–5.
Mohanty AJ, et al. Reuse of the Masseteric nerve for dynamic reanimation in facial palsy patients with previously failed one-stage dynamic smile reanimation. Plast Reconstr Surg. 2019;143(2):567–71.
Zhang S, et al. Early Masseter to facial nerve transfer may improve smile excursion in facial paralysis. Plast Reconstr Surg Glob Open. 2018;6(11):e2023.
Murphey AW, Clinkscales WB, Oyer SL. Masseteric Nerve transfer for facial Nerve paralysis: a systematic review and meta-analysis. JAMA Facial Plast Surg. 2018;20(2):104–10.
Godefroy WP, et al. Intratemporal facial nerve transfer with direct coaptation to the hypoglossal nerve. Otol Neurotol. 2007;28(4):546–50.
Owusu JA, Truong L, Kim JC. Facial nerve reconstruction with concurrent Masseteric nerve transfer and cable grafting. JAMA Facial Plast Surg. 2016;18(5):335–9.
Jowett N, et al. Toward the bionic face: a novel neuroprosthetic device paradigm for facial reanimation consisting of neural blockade and functional electrical stimulation. Plast Reconstr Surg. 2019;143(1):62e–76e.
Skourtis ME, et al. Immediate Gore-Tex sling suspension for management of facial paralysis in head and neck extirpative surgery. Otolaryngol Head Neck Surg. 2007;137(2):228–32.
Garcia RM, et al. Contemporary solutions for the treatment of facial nerve paralysis. Plast Reconstr Surg. 2015;135(6):1025e–46e.
Labbe D, Huault M. Lengthening temporalis myoplasty and lip reanimation. Plast Reconstr Surg. 2000;105(4):1289–97; discussion 1298
Byrne PJ, et al. Temporalis tendon transfer as part of a comprehensive approach to facial reanimation. Arch Facial Plast Surg. 2007;9(4):234–41.
Lindsay RW, et al. A systematic algorithm for the management of lower lip asymmetry. Am J Otolaryngol. 2011;32(1):1–7.
Oyer SL, et al. Comparison of objective outcomes in dynamic lower facial reanimation with temporalis tendon and Gracilis free muscle transfer. JAMA Otolaryngol Head Neck Surg. 2018;44:1162–8.
Chuang DC, et al. Comparison of functional results after cross-face nerve graft-, spinal accessory nerve-, and Masseter nerve-innervated Gracilis for facial paralysis reconstruction: the Chang Gung experience. Ann Plast Surg. 2018;81.(6S Suppl 1:S21–9.
Boahene KO, et al. The multivector Gracilis free functional muscle flap for facial reanimation. JAMA Facial Plast Surg. 2018;20(4):300–6.
Bhama PK, et al. Objective outcomes analysis following microvascular Gracilis transfer for facial reanimation: a review of 10 years’ experience. JAMA Facial Plast Surg. 2014;16(2):85–92.
Harii K, et al. One-stage transfer of the latissimus Dorsi muscle for reanimation of a paralyzed face: a new alternative. Plast Reconstr Surg. 1998;102(4):941–51.
Takushima A, et al. Neurovascular free-muscle transfer for the treatment of established facial paralysis following ablative surgery in the parotid region. Plast Reconstr Surg. 2004;113(6):1563–72.
Jowett N, Hadlock TA. Free Gracilis transfer and static facial suspension for midfacial reanimation in long-standing flaccid facial palsy. Otolaryngol Clin N Am. 2018;51(6):1129–39.
Henstrom DK, et al. Platysmectomy: an effective intervention for facial synkinesis and hypertonicity. Arch Facial Plast Surg. 2011;13(4):239–43.
Azizzadeh B, et al. Modified selective neurectomy for the treatment of post-facial paralysis synkinesis. Plast Reconstr Surg. 2019;143(5):1483–96.
Ridley F. Therapeutic uses of scleral contact lenses. Int Ophthalmol Clin. 1962;2:687–716.
Tan DTH, Pullum KW, Buckley RJ. Medical applications of scleral contact lenses, 2: gas permeable scleral contact lenses. Cornea. 1995;14:130–7.
Grey F, Carley F, Biswas S, Tromans C. Scleral contact lens management of bilateral exposure and neutrophic keratopathy. Cont Lens Anterior Eye. 2012;35:288–91.
Harthan JS, Shorter E. Therapeutic uses of scleral contact lenses for ocular surface disease: patient selection and special considerations. Clin Optom. 2018;10:65–74.
Rosenthal P, Croteau A. Fluid-ventilated, gas permeable scleral contact lens is an effective option for managing severe ocular surface disease and many corneal disorders that would otherwise require penetrating keratoplasty. Eye Contact Lens. 2005;31(1):130–4.
Schornack MM. Scleral lenses: a literature review. Eye Contact Lens. 2015;41:3–11.
Pullum KW, Stapleton FJ. Scleral lens induced corneal swelling: what is the effect of varying Dk and lens thickness? CLAO J. 1997;23:259–63.
Giasson CJ, Morency J, Melillo M, Michaud L. Oxygen tension beneath scleral lenses of different clearances. Optom Vis Sci. 2017;94:466–75.
Walker MK, Bergmanson JP, Miller WL, Marsack JD, Johnson LA. Complications and fitting challenges associated with scleral contact lenses: a review. Cont Lens Anterior Eye. 2016;39:88–96.
Robinson MW, Baiungo J. Facial rehabilitation: evaluation and treatment strategies for patients with facial palsy. Otolarynogol Clin North Am. 2018;51:1151–67.
Ross BG, Fradet G, Nedzelski JM. Developments of a sensistive clinical facial grading system. Otolaryngol Head Neck Surg. 1996;111(3):380–6.
Banks CA, Bhama PK, et al. Clinician-graded electronic facial paralysis assessment: the eFACE. Plast Reconstr Surg. 2015;136(2):223–30.
Kahn JH, Ngo RYS. Validation of a patient-graded instrument of facial nerve paralysis: the FaCE scale. Larynogoscope. 2001;123(5):387–98.
Coulson SE, O’dwer NJ, et al. Expression of emotion and quality of life after facial nerve paralysis. Otol Neurotol. 2004;25(6):1014–9.
VanSwearingen JM, Brach JS. The facial disability index: reliability and validity of a disability assessment instrument for disorders of the facial neuromuscular system. Phys Ther. 1996;76(12):1288–98, 300.
VanSweringen JM. Facial rehabilitation: a neuromuscular reeducation, patient-centered approach. Facial Plast Surg. 2008;24(2):250–9.
Brach JS, VanSwearingen J. Physical therapy for facial paralysis: a tailored treatment approach. Phys Ther. 1999;79:397–404.
Tuncay F, Borman P, et al. Role of electrical stimulation added to conventional therapy in patients with idiopathic facial (Bell) palsy. Am J Phys Med Rehabil. 2015;94(3):222–8.
Hyvarinen A, Tarkka I, et al. Cutaneous electrical stimulation treatment in unresolved facial nerve paralysis. Am J Phys Med Rehabil. 2008;87(12):992–7.
Fuiwara K, Furuta Y, et al. Factors affecting the effect of physical rehabilitation therapy for synkinesis as a sequela to facial nerve palsy. Auris Nasus Larynx. 2017;45:732–9.
Fuiwara K, Furuta Y, et al. Comparison of facial synkinesis at 6 and 12 months after the onset of peripheral facial palsy. Auris Nasus Larynx. 2015;42:271–4.
Lee JM, Choi KH, et al. Half-mirror biofeedback exercise in combination with three botulinum toxin a injections for long-lasting treatment of facial sequelae after facial paralysis. J Plast Reconstr Aesthet Surg. 2015;68:71–8.
Allison Munn, Michelle Cameron, Myriam Loyo. Trends in Electric Stimulation for Facial Paralysis: Electronic Survey of Physical Therapists in Oregon. Archives of Physiotherapy and Rehabilitation 3 (2020):001–008.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Loyo, M., Ng, J.D., Louie, D., McReynolds, M. (2020). Evaluation and Management of Facial Palsy. In: Albert, D., Miller, J., Azar, D., Young, L.H. (eds) Albert and Jakobiec's Principles and Practice of Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-319-90495-5_88-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-90495-5_88-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90495-5
Online ISBN: 978-3-319-90495-5
eBook Packages: Springer Reference MedicineReference Module Medicine